Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81,755Revenue $M19,616Net Margin (%)12.2Z-Score2.7
Enterprise Value $M84,999EPS $2.2Operating Margin %17.0F-Score4
P/E(ttm))33.2Cash Flow Per Share $5.4Pre-tax Margin (%)15.3Higher ROA y-yN
Price/Book5.510-y EBITDA Growth Rate %10.8Quick Ratio0.8Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-6.0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-39.0ROA % (ttm)6.8Higher Current Ratio y-yN
Dividend Yield %2.7Insider Buy (3m)0ROE % (ttm)13.7Less Shares Outstanding y-yY
Payout Ratio %88.0Shares Outstanding M1,111ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 73.588%Reduce -92.65%169,348
LLYJohn Hussman 2014-12-31 Reduce-0.29%$61.9 - $72.83
($67.53)
$ 73.588%Reduce -17.21%252,500
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 73.588%Add 383.26%578,992
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 73.588%Sold Out0
LLYJohn Hussman 2014-09-30 Add1.67%$60.35 - $66.59
($63.3)
$ 73.5814%Add 6000.00%305,000
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 73.5814%Reduce -14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 73.5814%Reduce -10.92%4,321,666
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 73.5814%Reduce -84.40%900
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 73.5814%Add 2742.47%119,810
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 73.5814%Sold Out0
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 73.5819%Add 199.70%4,851,480
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 73.5819%Reduce -3.98%21,982,700
LLYJohn Hussman 2014-06-30 Reduce-0.02%$58.21 - $63.1
($59.62)
$ 73.5819%Reduce -50.00%5,000
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 73.5819%New holding50,441
LLYRay Dalio 2014-06-30 Sold Out -0.02%$58.21 - $63.1
($59.62)
$ 73.5819%Sold Out0
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 73.5824%Add 10.83%57,129,708
LLYHOTCHKIS & WILEY 2014-03-31 Buy 0.35%$50.73 - $59.85
($55.61)
$ 73.5824%New holding1,618,802
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 73.5824%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 73.5824%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 73.5832%Add 22.98%22,895,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.97-4.59view
Fry Stephen FSVP, HR & Diversity 2015-03-09Sell4,000$69.276.02view
Zakrowski Donald AChief Accounting Officer 2015-02-05Sell374$71.033.39view
Rice Derica WEVP-Global Services and CFO 2015-02-04Sell5,316$704.91view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-04Sell11,085$70.084.79view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-04Sell3,147$69.994.93view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-03Sell121,711$70.783.76view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-02Sell4,769$71.512.7view
Rice Derica WEVP-Global Services and CFO 2015-02-02Sell10,068$71.842.23view
LILLY ENDOWMENT INC10% Owner 2014-12-04Sell190,000$71.922.11view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 
    Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 

    More From Other Websites
    Biogen data reignites debate over Alzheimer's cause as investors back off (Video) Mar 25 2015
    Pfizer (PFE) Is The 'Chart of the Week' Mar 25 2015
    Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab Mar 25 2015
    Why All Those Testosterone Ads Constitute Disease Mongering Mar 24 2015
    Pfizer & Eli Lilly to Resume Phase III Study of Tanezumab - Analyst Blog Mar 24 2015
    Eli Lilly Partners with Innovent to Develop Oncology Drugs - Analyst Blog Mar 23 2015
    Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog Mar 23 2015
    Pfizer and ImmunoGen are big market movers Mar 23 2015
    Pfizer and ImmunoGen are big market movers Mar 23 2015
    How Lilly and Amgen Are Going in Opposite Directions Mar 23 2015
    Eli Lilly (LLY) Stock Gains Today After FDA Lifts Ban on Pain Treatment Drug Trials Mar 23 2015
    FDA recommends no changes to Lilly's schizophrenia injection use Mar 23 2015
    Teva Migraine Drug Scores In Race With Alder, Lilly Mar 23 2015
    SunTrust Names Eli Lilly, Merck, Bristol-Myers as 'Favorite' Pharma Firms Mar 23 2015
    4 Stocks, 4 trades: Staples, Lululemon & more Mar 23 2015
    3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary Mar 23 2015
    Pfizer, Lilly to resume study testing pain drug Mar 23 2015
    Pfizer's stock jumps to near 11-year high Mar 23 2015
    Pfizer, Lilly to Resume Studies of Pain Treatment Tanezumab Mar 23 2015
    4 Pharmaceutical Stocks to Buy for Outperformance in 2015 Mar 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK